Key Takeaways
- The MTRR gene mutation disrupts methylation and raises homocysteine levels.
- Symptoms may include heart issues, birth defects, cognitive, and mental problems.
- Supportive supplements have been linked to B12, folate, folic acid and betaine; individualized care is essential.
- DNA methylation is essential; MTRR mutations may cause widespread effects throughout the body.
- MTRR Gene mutation treatment can only begin after the genetic testing information is interpreted.
What Are the MTRR Genes?
MTRR (methionine synthase reductase) is a gene that supports an enzyme called methionine synthase reductase, which helps regenerate another enzyme, MTR (methionine synthase), also known as human methionine synthase, which converts homocysteine into methionine, an essential amino acid vital for protein synthesis and a key player in metabolism, cell growth, and function in mammals.
This methyltransferase reductase gene plays a central role in the metabolism of amino acids, that may help with an information to recycle vitamin B12 and maintain balanced homocysteine and folate metabolism. When these genes don’t work correctly, this process slows down, which may affect overall health.1
Both MTR and MTRR are required for the proper recycling of vitamin B12 and maintaining normal homocysteine levels. Studies suggest that disruptions in their activity may lead to elevated homocysteine, affecting cardiovascular health and other related metabolic functions.2,3
What Is an MTRR Gene Mutation?
An MTRR gene mutation basically means there’s a tiny change in the DNA that affects how well an enzyme called methionine synthase reductase functions in the body. MTR A66G is one of the most common variants of this change, in which Guanine replaces a single Adenine in the DNA. It might sound small, but this little change can slow the breakdown of homocysteine, which can build up if not processed properly.5
Other changes in the MTRR gene (like C524T) may even make the enzyme less effective. The body’s normal DNA repair and regulatory processes are affected when this happens, which may increase the risk of genetic problems and related health conditions over time.6
What causes and what are the risk factors associated with MTRR gene mutation?
MTRR gene mutations are typically inherited through compound heterozygosity, meaning a person has two distinct mutations in the same gene, or single-homozygous mutations, meaning both copies of the gene harbor the same mutation.
Risk factors for developing complications are associated with genetic predisposition, combined with low levels of dietary folate or vitamin B12 deficiency, and specific environmental influences like smoking; a poor diet may worsen the impact of these mutations without directly causing them.4 These mutations have been linked to neural tube defects, congenital heart defects, and risks like Down syndrome.5
How does MTRR gene mutation impact health?
When the MTRR gene doesn’t function correctly, it disrupts the conversion of homocysteine to methionine by another enzyme called methionine synthase (MTR). As a result, plasma homocysteine levels may gradually rise (Hyperhomocysteinemia) while methionine levels drop, often leading to a functional vitamin B12 deficiency that may further indicate a potential synthase reductase deficiency and overall methylation efficiency. This imbalance has been linked to interfering with the body’s ability to repair its DNA and perform many critical cellular functions. Keeping these processes in balance is vital for staying healthy, and understanding how they work could help create better ways to support overall wellness.
What are the common symptoms of MTRR gene mutation?
MTRR or MTHFR (methylenetetrahydrofolate reductase) gene mutations may cause diverse symptoms that have been linked to affect multiple systems of the human body. The severity and type of symptoms can vary depending on the underlying genetic variant and additional risk factor exposure, such as nutritional deficiencies or environmental stressors.
What are the Physical Symptoms?
- Cardiovascular Risks (including heart attack and cerebral stroke).
- Neural tube defects like spina bifida and congenital abnormalities in children.6,7
- Vision issues, such as retinal neurovasculopathies 8
What are the Cognitive and Mental Symptoms?
- Developmental delays and learning disabilities in children.
- Cognitive decline in adults, including memory and concentration issues.9
- Psychiatric conditions such as schizophrenia or other mental abnormalities may occur.9
What are the Long-term Health Risks?
- Increased risk of megaloblastic anemia and blood clots.10
- Higher susceptibility to certain cancers (urinary bladder cancer).11
- Osteoporosis and poor bone health.12
What supplements may be beneficial for MTRR gene mutation?
Specific nutrients may act as medicine, helping support individuals with MTRR or MTHFR gene mutations by optimizing methylation pathways and correcting underlying B-vitamin deficiency.
Vitamins and Nutrients
- Vitamin B12 (methylcobalamin): This vitamin is an essential cofactor for methionine synthase. Supplementation may enhance methionine synthase activity and address B12 deficiency, but it does not directly correct the genetic mutation.
- Folate (5-methyltetrahydrofolate, 5-MTHF): This form of folate has been linked to actively supporting methylation and helps lower homocysteine levels.13
- Betaine: This nutrient may aid in homocysteine metabolism through alternative pathways.
- Vitamin B6 and riboflavin: These vitamins may support cofactor recycling and are involved in methylation reactions.
It is important for supplement recommendations to be personalized and supervised by a medical professional, especially for individuals with genetic mutations. Excessive nutrient supplementation may cause adverse effects.
Caution: These supplements support methylation but do not reverse genetic mutations.
What Is Methylation and Why It’s Important?
DNA methylation is a natural body process that refers to the addition of a methyl group (CH3) to various molecular targets.14 It is a key natural process that primarily controls gene expression, turning genes on or off as needed. The genes involved in this pathway are essential for cells to function correctly and for the body’s normal growth and development.
The MTR and MTRR genes support this process and are involved in homocysteine to methionine conversion, which keeps the methylation cycle active. When the MTRR gene is mutated, it may disrupt its regulation, potentially linked to developmental problems and an increased risk of various diseases.
How Do I Know If I Have an MTRR Gene Mutation?
Genetic testing serves as a valuable tool for identifying whether an individual possesses a mutation in the MTRR gene. Research articles from institutions such as the U.S. National Library of Medicine provide detailed insights into how MTRR and related genes affect methylation and vitamin B12 recycling.
What Are the Methods for Genetic Testing?
- Laboratory Blood Tests: Blood test information helps to detect specific mutation variants (such as A66G and C524T) utilizing techniques including Polymerase Chain Reaction (PCR), sequencing, or genotyping.15
- Direct-to-Consumer DNA Testing Kits: While these kits may provide preliminary screening for common genetic variants, their test results must be interpreted with serious attention and caution and under the supervision of a qualified healthcare professional.
How Are Genetic Testing Results Interpreted?
Results from genetic testing will classify the individual as follows:
Homozygous: Presence of two mutated alleles, which may indicate a more severe form of the disease.
Heterozygous: Presence of one mutated allele, which may indicate less severe symptoms.
Wild type: The absence of mutations.
Healthcare professionals utilize this information to inform decisions regarding additional testing, supplementation, and medicine protocols, and overall risk management strategies.
Consulting a certified genetic counselor is recommended before making any medical or nutritional decisions based on test results.
References-
- Paul J. Converse. METHIONINE SYNTHASE REDUCTASE; MTRR. 2017. 5:7,850,859-7,901,113
- Son P, Lewis L. Hyperhomocysteinemia. [Updated 2022 May 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554408/
- Huang C. C. (2024). Case report: Rare variants in the MTRRgene, 66GG and 524TT cause hyperhomocysteinemia and folic acid deficiency linked to schizophrenia. Frontiers in psychiatry, 15, 1353308. https://doi.org/10.3389/fpsyt.2024.1353308
- Ruiz-Mercado, M., Vargas, M. T., de Soto, I. P., Pecellín, C. D., Sánchez, M. C., Delgado, M. A., Ruiz, R. B., Pérez-Simón, J. A., & Díaz-Aguado, A. H. (2016). Methionine synthase reductase deficiency (CblE): A report of two patients and a novel mutation. Hematology (Amsterdam, Netherlands), 21(3), 193–197. https://doi.org/10.1179/1607845415Y.0000000017
- Yadav, U., Kumar, P., & Rai, V. (2021). Distribution of Methionine Synthase Reductase (MTRR) Gene A66G Polymorphism in Indian Population. Indian journal of clinical biochemistry : IJCB, 36(1), 23–32. https://doi.org/10.1007/s12291-019-00862-9
- Deng, L., Elmore, C. L., Lawrance, A. K., Matthews, R. G., & Rozen, R. (2008). Methionine synthase reductase deficiency results in adverse reproductive outcomes and congenital heart defects in mice. Molecular genetics and metabolism, 94(3), 336–342. https://doi.org/10.1016/j.ymgme.2008.03.004
- O’Leary, V. B., Parle-McDermott, A., Molloy, A. M., Kirke, P. N., Johnson, Z., Conley, M., Scott, J. M., & Mills, J. L. (2002). MTRR and MTHFR polymorphism: link to Down syndrome?. American journal of medical genetics, 107(2), 151–155. https://doi.org/10.1002/ajmg.10121
- Markand, S., Saul, A., Roon, P., Prasad, P., Martin, P., Rozen, R., Ganapathy, V., & Smith, S. B. (2015). Retinal Ganglion Cell Loss and Mild Vasculopathy in Methylene Tetrahydrofolate Reductase (Mthfr)-Deficient Mice: A Model of Mild Hyperhomocysteinemia. Investigative ophthalmology & visual science, 56(4), 2684–2695. https://doi.org/10.1167/iovs.14-16190
- Huang C. C. (2024). Case report: Rare variants in the MTRRgene, 66GG and 524TT cause hyperhomocysteinemia and folic acid deficiency linked to schizophrenia. Frontiers in psychiatry, 15, 1353308. https://doi.org/10.3389/fpsyt.2024.1353308
- Kniffin CL. HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblG TYPE; HMAG.2013. 156570
- Gautam, K. A., Raghav, A., Sankhwar, S. N., Singh, R., & Tripathi, P. (2023). Genetic Polymorphisms of Gene Methionine Synthase Reductase (MTRR) and Risk of Urinary Bladder Cancer. Asian Pacific journal of cancer prevention : APJCP, 24(4), 1137–1141. https://doi.org/10.31557/APJCP.2023.24.4.1137
- Li, D., & Wu, J. (2010). Association of the MTHFR C677T polymorphism and bone mineral density in postmenopausal women: a meta-analysis. Journal of biomedical research, 24(6), 417–423. https://doi.org/10.1016/S1674-8301(10)60056-5
- Carboni L. (2022). Active Folate Versus Folic Acid: The Role of 5-MTHF (Methylfolate) in Human Health. Integrative medicine (Encinitas, Calif.), 21(3), 36–41.
- Menezo, Y., Clement, P., Clement, A., & Elder, K. (2020). Methylation: An Ineluctable Biochemical and Physiological Process Essential to the Transmission of Life. International journal of molecular sciences, 21(23), 9311. https://doi.org/10.3390/ijms21239311
- Wang, W., Jiao, X. H., Wang, X. P., Sun, X. Y., & Dong, C. (2016). MTR, MTRR, and MTHFR Gene Polymorphisms and Susceptibility to Nonsyndromic Cleft Lip With or Without Cleft Palate. Genetic testing and molecular biomarkers, 20(6), 297–303. https://doi.org/10.1089/gtmb.2015.0186





